154 related articles for article (PubMed ID: 38041154)
21. Consistency and prognostic value of preoperative staging and postoperative pathological staging using
Kajiyama A; Ito K; Watanabe H; Mizumura S; Watanabe SI; Yatabe Y; Gomi T; Kusumoto M
Ann Nucl Med; 2022 Dec; 36(12):1059-1072. PubMed ID: 36264439
[TBL] [Abstract][Full Text] [Related]
22. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
[TBL] [Abstract][Full Text] [Related]
23. Total lesion glycolysis by 18F-FDG PET/CT is independent prognostic factor in patients with advanced non-small cell lung cancer.
Yıldırım F; Yurdakul AS; Özkaya S; Akdemir ÜÖ; Öztürk C
Clin Respir J; 2017 Sep; 11(5):602-611. PubMed ID: 26434685
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of anthropometric measures extracted from whole-body CT using deep learning in patients with non-small-cell lung cancer.
Blanc-Durand P; Campedel L; Mule S; Jegou S; Luciani A; Pigneur F; Itti E
Eur Radiol; 2020 Jun; 30(6):3528-3537. PubMed ID: 32055950
[TBL] [Abstract][Full Text] [Related]
25. Validation of Independent Prognostic Value of Asphericity of
Rogasch JMM; Furth C; Chibolela C; Hofheinz F; Ochsenreither S; Rückert JC; Neudecker J; Böhmer D; von Laffert M; Amthauer H; Frost N
Clin Lung Cancer; 2020 May; 21(3):264-272.e6. PubMed ID: 31839531
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
[TBL] [Abstract][Full Text] [Related]
27. The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer.
Shoji F; Haratake N; Akamine T; Takamori S; Katsura M; Takada K; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Feb; 37(2):741-747. PubMed ID: 28179325
[TBL] [Abstract][Full Text] [Related]
28. Preoperative identification of clinicopathological prognostic factors for relapse-free survival in clinical N1 non-small cell lung cancer: a retrospective single center-based study.
Aragaki M; Kato T; Fujiwara-Kuroda A; Hida Y; Kaga K; Wakasa S
J Cardiothorac Surg; 2020 Aug; 15(1):229. PubMed ID: 32859238
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of the advanced lung cancer inflammation index in early-stage non-small cell lung cancer patients undergoing video-assisted thoracoscopic pulmonary resection.
Wang Y; Lin L; Ji Y; Mei X; Zhao C; Chen Y; Che G
Ann Palliat Med; 2020 May; 9(3):721-729. PubMed ID: 32312059
[TBL] [Abstract][Full Text] [Related]
30. Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study.
Li SJ; Zhao L; Wang HY; Zhou HN; Ju J; Du H; Che GW
Int J Surg; 2020 Dec; 84():25-40. PubMed ID: 33086147
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall.
Jones GD; Caso R; No JS; Tan KS; Dycoco J; Bains MS; Rusch VW; Huang J; Isbell JM; Molena D; Park BJ; Jones DR; Rocco G
Eur J Cardiothorac Surg; 2020 Jul; 58(1):78-85. PubMed ID: 32040170
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
33. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.
Wang T; She Y; Yang Y; Liu X; Chen S; Zhong Y; Deng J; Zhao M; Sun X; Xie D; Chen C
Radiology; 2022 Feb; 302(2):425-434. PubMed ID: 34726531
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC.
Lee J; Cui Y; Sun X; Li B; Wu J; Li D; Gensheimer MF; Loo BW; Diehn M; Li R
Eur Radiol; 2018 Feb; 28(2):736-746. PubMed ID: 28786009
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of TLR from FDG PET/CT in patients with margin-negative stage IB and IIA non-small cell lung cancer.
Park HL; Boo SH; Park SY; Moon SW; Yoo IR
Eur Radiol; 2023 Oct; 33(10):7274-7283. PubMed ID: 37060445
[TBL] [Abstract][Full Text] [Related]
36. Low truncal muscle area on chest computed tomography: a poor prognostic factor for the cure of early-stage non-small-cell lung cancer†.
Sun C; Anraku M; Karasaki T; Kuwano H; Nagayama K; Nitadori JI; Sato M; Nakajima J
Eur J Cardiothorac Surg; 2019 Mar; 55(3):414-420. PubMed ID: 30289481
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer.
Chen Q; Shao J; Xue T; Peng H; Li M; Duan S; Feng F
Eur Radiol; 2023 Feb; 33(2):947-958. PubMed ID: 36064979
[TBL] [Abstract][Full Text] [Related]
38. Computed tomography (CT) predicts accurately the pathologic tumour size in stage I non-small-cell lung cancer (NSCLC).
Cedrés S; Quispe I; Martínez P; Longo M; Rodríguez E; Serrano C; Muñoz E; Pallisa E; Felip E
Clin Transl Oncol; 2010 Dec; 12(12):829-35. PubMed ID: 21156414
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
Liu J; Dong M; Sun X; Li W; Xing L; Yu J
PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114
[TBL] [Abstract][Full Text] [Related]
40. Preoperative Pulmonary Function Tests (PFTs) and Outcomes from Resected Early Stage Non-small Cell Lung Cancer (NSCLC).
Almquist D; Khanal N; Smith L; Ganti AK
Anticancer Res; 2018 May; 38(5):2903-2907. PubMed ID: 29715115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
